Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Hayden Michael R bought 20,000 Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 30 to Jul 31, 2026 · Filed Jul 31, 2026
From Jul 30 to Jul 31, 2026, Hayden Michael R (Director) bought 20,000 Ionis Pharmaceuticals, Inc. shares at an average US$52.94 for US$1.06M, leaving 24,000 shares. Filed Jul 31, 2026 (Form 4).
- Bought
- 20,000 shares
- Price
- US$52.94 average (US$51.60 to US$53.38)
- Value
- US$1.06M
- Holding after
- 24,000 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | Buy | 15,000 | US$53.38 | 19,000 | Indirect |
| Jul 31, 2026 | Common Stock | Buy | 5,000 | US$51.60 | 24,000 | Indirect |